U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639593) titled 'Trial of CGM Technology in Persons Living With Prediabetes' on June 05.
Brief Summary: Continuous glucose monitor (CGM) technology has become increasingly prevalent in the population and has the ability to transform care of patients living with prediabetes. While the technology was initially utilized primarily by patients living with type 1 diabetes using insulin pump therapy, it has become more widely used as part of care in patients living with type 1 or 2 diabetes on any kind of insulin therapy.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Prediabetes
Intervention:
DEVICE: Stelo CGM
The Stelo Glucose ...